VEGFA and breast carcinoma: Recently, site specific labeled Tc-99m-hydrazine nicotinamide (HYNIC)-VEGF has been used for the imaging of mouse model tumor (4T1 murine mammary carcinoma) vasculature before and after antiangiogenic therapies [22].